SCHEMBL7102226

SCHEMBL7102226

c1cnc2c(c1)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7476995 1.00 SMN1; SMN2 (0.55)
SCHEMBL8103221 0.92 GSK3B (0.50)
SCHEMBL15326919 0.87 GSK3B (0.47)
SCHEMBL2420515 0.80 CYP1A2 (0.77)
SCHEMBL2511237 0.80 CYP1A2 (0.53)
SCHEMBL6745596 0.78 SMN1; SMN2 (0.55)
SCHEMBL7337375 0.77 HTR5A (0.47)
SCHEMBL5178865 0.77 CYP1A2 (0.80)
SCHEMBL9793307 0.76 CYP1A2 (0.67)
SCHEMBL31095197 0.75 GAA (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110776406-B Novel Friedel-Crafts reaction method and catalyst thereof 福建永晶科技股份有限公司 2022-11-04 CN disclosed
CN-110776406-A Novel Friedel-Crafts reaction method and catalyst thereof 福建永晶科技股份有限公司 2020-02-11 CN disclosed
EP-1194401-B1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GMBH (DE) 2003-09-10 EP disclosed
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed
EP-1194401-A1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GmbH (DE) 2002-04-10 EP disclosed
WO-2001005753-A1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GMBH (DE) 2001-01-25 WO disclosed